Podcasts about dmd

The DMD is here! Sounders tied. Mariners didn't play, and we talk calling people the wrong name!

The DMD is here! We love informing you! Plus let's chat about going to the zoo!

Up to 3,500 FDA staffers received their final walking papers Monday after the U.S. Supreme Court found last week that the government is “likely to succeed” in arguing that its overhaul of HHS is “lawful.” Meanwhile, FDA Commissioner Marty Makary floated policy changes for the agency, including a proposal to lower prescription drug user fees for the next iteration of the program, and one to offer speedier reviews to companies willing to lower the cost of their drugs.  Last week, the regulator opened its cache of complete response letters (CRLs), offering transparency into the rationale behind more than 200 recent rejections for ultimately approved therapies, including those for Eli Lilly's Alzheimer's drug Kisunla and Sarepta's Duchenne muscular dystrophy (DMD) treatment Vyondys 53. The FDA did not, however, release the CRLs for two new rejections: those of therapies from Ultragenyx and Capricor Therapeutics in Sanfilippo syndrome type A and cardiomyopathy associated with DMD, respectively. It was an especially rough week for Ultragenyx, which also, along with partner Mereo BioPharma, released seemingly negative Phase II/III data for their osteogenesis imperfecta therapy.  On a more positive note, two bustling therapeutic spaces continue to see positive data. In obesity, Hengrui Pharma's Kailera Therapeutics–partnered dual GLP-1/GIP receptor agonist elicited 17.7% average weight loss in a pivotal Chinese trial. And the psychedelic therapeutics space is again generating excitement with two recent positive readouts in treatment-resistant depression. BioSpace took a deep dive into the market reaction to these readouts for Compass Pathways and Beckley Psytech and atai Life Sciences, and what exactly investors are looking for in a successful psychedelic therapy.  Finally, we examine the progress of AI biotech unicorns and kick off our series on women in biopharma with profiles on Mayo Venture Partner Audrey Greenberg and the all-female CEO/R&D tandem at Acadia Pharmaceuticals.  

THE DMD is here! And we are ready to go! Cal Raleigh won the HOMERUN DERBY!

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. Takeda has taken the lead in the race for a narcolepsy treatment with back-to-back phase III wins for their drug Oveporexton. Investors are eagerly awaiting breakthroughs in using psychedelics to treat depression. Ultragenyx faced a setback as the FDA rejected their gene therapy for Sanfilippo syndrome, citing manufacturing issues. The FDA is considering speeding up reviews for companies that promise to lower drug costs. Market reaction to recent readouts from Compass Pathways and Beckley Psytech/Atai in treatment-resistant depression shows the challenges psychedelic therapies must overcome for commercial viability. Rainin Micropro offers a solution to streamline NGS preparation with their 96-channel pipettor. The industry is also focused on precision diagnostics to support precision therapeutics in the future. AstraZeneca's Baxdrostat showed promising results in lowering blood pressure in a phase III trial. The ADA revealed R&D priorities for potential blockbuster obesity treatments. Relmada has abandoned development of a depression drug after three failed attempts.The challenges faced by psychedelic therapies in the treatment of depression are discussed, as recent readouts from Compass Pathways and Beckley Psytech/Atai in treatment-resistant depression have left investors wanting more. The market reaction highlights the hurdles psychedelic therapies must overcome to prove their commercial viability. Additionally, the importance of precision diagnostics in the development of next-generation precision oncology therapies is emphasized, stating that only with the adoption of digital imaging and AI-powered analysis will these therapies reach their full potential. The FDA has several important decisions lined up, including applications in lymphoma, rare diseases, and hormone deficiency, while the American Diabetes Association's annual meeting reveals R&D priorities for weight loss medicines. Topics discussed include Capricor's FDA rejection of a DMD cell therapy, the ALS community petitioning the FDA to reconsider Brainstorm's Nurown, and updates on COVID-19 vaccines and Alzheimer's drugs. Upcoming webinars and job opportunities in the biopharma industry are also included.

The DMD is here! And we wanna chat with you about CAMPING!

Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.The FDA has rejected Capricor's therapy for Duchenne Muscular Dystrophy (DMD), causing shares to plunge due to insufficient evidence of effectiveness for cardiomyopathy associated with DMD. Lilly and Sarepta also received Complete Response Letters (CRLs) for their therapies. Moderna has won full approval for its COVID-19 vaccine for higher-risk kids, while Pacira has cut staff in San Diego. The FDA has released a cache of CRLs, providing insights into the journeys to market for various drugs. AbbVie has acquired Ichnos Glenmark's lead myeloma antibody, and Ultragenyx's stock plummeted after a late-stage trial disappointment. Kennedy postponed a preventive care panel meeting after a Supreme Court win. Transitioning from one piece of news to the next, let's move on to the webinar exploring digitization strategies for drug development. Stay tuned for more updates in the pharmaceutical industry.

Happy Thursday! The DMD is here and we are talking swear words! Plus donate now to Kicks for Kids at KISW.com!

THE DMD is here! Are you ready! Let's also chat about what you stole?

The DMD is here on a Tuesday! Plus we chat about rockstar names!

Happy Wednesday! The DMD is here! Let's chat about The Mariners losing.

The DMD is here! And let's chat about what your kid did for you!

The DMD is here! And we chat about role play!

In this episode of Talking Sleep, Drs. Michelle Cantwell and Aaron Glick discuss the updated American Academy of Dental Sleep Medicine (AADSM) Standards for Practice. Dr. Michelle Cantwell received her DMD through the University of Pittsburgh's School of Dental Medicine, where she also completed a three-year residency in prosthodontics. Following dental school, she served as a lieutenant commander in the US Navy. She is a diplomate of the ABDSM and the president-elect of the AADSM. She works in the pulmonary and sleep medicine department of WellSpan Health. Aaron Glick, DDS, FAGD, FICOI, D.ABDSM, is a dentist who has committed his practice to dental sleep medicine. He has been recognized as a “Top 10 Dentist to Watch” and works clinically utilizing teledentistry for efficient patient care. Dr. Glick educates fellow practitioners as the Mastery Program Director at the American Academy of Dental Sleep Medicine, focusing on mandibular advancement devices. Additionally, he is on the faculty at the University of Texas Health Science Center at Houston School of Dentistry. He actively lectures nationally and publishes on obstructive sleep apnea and technology. He enjoys all technologies and has a medical device and software programming background

DMD is here and we are ready to go!

The DMD is here! And we are ready to go on a hump day! Plus let's chat nick names!

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. Sarepta Therapeutics faced a drop in shares due to a second death from acute liver failure in a patient receiving their DMD gene therapy. On the other hand, Sage Therapeutics had a positive outcome with a $795 million acquisition by Supernus, surpassing a bid from Biogen. Meanwhile, Lilly saw promising results in a phase I study of their amylin/tirzepatide combo for weight loss. J&J's dual-targeting CAR T-cell therapy showed an 80% complete response rate in early lymphoma studies, demonstrating potential in the field. In addition, Intellia Therapeutics is dedicated to developing potentially curative genome editing treatments for severe diseases, showing promise for future advancements in healthcare.

The tragic death of a second non-ambulatory DMD patient treated with Sarepta's Elevidys gene therapy marks a turning point for the field and should drive all stakeholders to come together to figure out how to safely treat patients with this new modality. On the latest BioCentury This Week podcast, BioCentury's analysts discuss the opportunity FDA, companies and patient advocates have to share data and identify a safe path forward for the gene therapy field, both in DMD and beyond.The analysts also review promising early data for amylin agonists to treat obesity from Metsera and Eli Lilly, and discuss the vision for FDA's future laid out by Commissioner Marty Makary and CBER director Vinay Prasad. This episode of BioCentury This Week was sponsored by ICON Biotech.View full story: https://www.biocentury.com/article/656214#biotech #biopharma #pharma #lifescience #obesity #FDA #DMD00:01 - Sponsor Message: ICON Biotech01:19 - Gene Therapy Safety11:55 - Amylin in Obesity18:17 - FDA's FutureTo submit a question to BioCentury's editors, email the BioCentury This Week team at podcasts@biocentury.com.Reach us by sending a text

Ep 324: Exploring Airway Health in Dentistry: Insights from Meggie Graham, DDS & Liz Turner, DMDThis week on the Untethered Podcast, Hallie welcomes Liz and Meggie from the Untethered Airway Health Center. They discuss the origins of their center and the importance of airway health in dentistry. Both Liz and Meggie dive into their personal journeys into airway-focused care and the establishment of their collaborative center. The conversation covers the holistic and interdisciplinary approach to treating tongue ties, the significance of pre and post-operative care, and how facial restrictions impact overall health. If this episode has resonated with you in some way, take a screenshot of you listening, post it to your Instagram Stories, and tag Hallie @halliebulkin and Meggie and Liz @untetheredairwayIn this episode, you'll hear:✔️ The origin of the Untethered Airway Health Center and its mission.✔️ Meggie's journey and collaboration with Liz.✔️ The importance of airway health in dentistry.✔️ Challenges in pediatric feeding and the role of myofunctional therapy.✔️ The value of comprehensive, interdisciplinary care.✔️ Cadaveric dissection and fascial connections.✔️ Identifying and treating airway issues in dentistry.✔️ The impact of orthodontics on airway health.✔️ Advocacy for children's health and educating providers and parents.✔️ New resources to advance airway health education.THIS WEEK:Doors to the Pediatric Feeding Hub are NOW OPEN! Get monthly mentorship from 5 experienced SLP and OT pediatric feeding specialists (plus the other members!) for a fraction of what a single consult would cost. https://pediatricfeedinghub.com/ LINKSGet to know Meggie Graham, DDS & Liz Turner, DMD on Instagram. Check out their website: https://untetheredairwayhealthcenter.com/aboutReady to turn your "myo eyes" on? Join our free training and learn how to screen patients for myo: https://www.feedthepeds.com/myo-webinarFind a myofunctional therapist here: www.themyodirectory.comConnect with Hallie on Instagram, Facebook & LinkedINHaven't left a review yet? Click here and thank you, as always, for being a listener! Want to watch more of the episode? Click here Hosted on Acast. See acast.com/privacy for more information.

Thursday is here! We got the DMD for you! And we chat about things you will always remember.

Duchenne Muscular Dystrophy, or DMD as it is commonly known, is a progressive neuromuscular disease that causes the weakening of muscles over time.It affects almost exclusively boys, with symptoms typically appearing between the ages of one and three. In Ireland today, around 110 people are known to be living with DMD. Most of them are under the age of 18.Fianna Fáil Senator Teresa Costello has called on the European Commission, HSE and Minister of Health to regulate the drug Givinostat here for children with DMD.Joining Kieran to discuss is Senator Teresa Costello, as well as Úna and Eilish, both parents of children who suffer from Muscular Dystrophy.

It's the DMD! And we are back from the Miles Montgomery Golf Tournament! Are we hungover? Probably. Also let's talk snakes!

Dr. Wilner would love your feedback! Click here to send a text! Thanks!Many thanks to Anjali Rajpal, DMD, for joining me on this episode of The Art of Medicine with Dr. Andrew Wilner! Dr. Rajpal practices cosmetic dentistry at Beverly Hills Dental Arts. During our 25-minute conversation, we discussed Dr. Rajpal's passion for hands-on creative work, like improving her patients' smiles. She explained that new electric tools vs air-powered ones have made the patient experience more comfortable. I Dr. Rajpal employs AI in her practice, which has many applications. Digital imaging powered by AI has replaced the old-fashioned and not entirely pleasant putty used to take impressions. Aesthetics can be fully realized with improved accuracy and efficiency. AI offers a "second set of eyes" to examine dental X-rays to ensure nothing is missed. Robots also assist with implant surgery. AI can also provide a look into the future for patients to see what their smile will look like after a complete makeover. To contact Dr. Rajpal, please check out her website:https://bhdentalarts.com Instagram, TikTok, YouTube: @beverlyhillsdentalartsPlease click "Fanmail" and share your feedback!If you enjoy an episode, please share with friends and colleagues. "The Art of Medicine with Dr. Andrew Wilner" is now available on Alexa! Just say, "Play podcast The Art of Medicine with Dr. Andrew Wilner!" To never miss a program, subscribe at www.andrewwilner.com. You'll learn about new episodes and other interesting programs I host on Medscape.com, ReachMD.com, and RadioMD.com. Please rate and review each episode. To contact Dr. Wilner or to join the mailing list: www.andrewwilner.com Finally, this production has been made possible in part by support from “The Art of Medicine's” wonderful sponsor, Locumstory.com, a resource where providers can get real, unbiased answers about locum tenens. If you are interested in locum tenens, or considering a new full-time position, please go to Locumstory.com. Or paste this link into your browser: https://locumstory.com/?source=DSP_directbuy_drwilnerpodcast_ph...

Friday is here! And we are ready with the DMD! Plus we chat all about friends!

The DMD is here! Let's go! Plus we chat about freak outs!

The DMD is here! And it's CHEESE DAY! What kind of cheese are you into?

The DMD is here! And we are ready to go! It's National Egg Day!

The DMD is here! And we dive into what crazy things you have seen at a show!

The DMD is here! And we chat about crazy pets! We know you have one!

We are here after Memorial day! Hope you are too and hope it was relaxing! Let's get going with the DMD!

Send us a textFlashing back to episode #72 of Fabulous Film & Friends way back in 2023, we covered Mission: Impossible – Dead Reckoning Part 1 and so we here on FFF felt duty bound to our fans to give our take on its follow up and what could very possibly be the final sequel to the entire M:I franchise, 2025's Mission: Impossible – The Final Reckoning directed by Christopher McQuarrie and starring Tom Cruise, Hayley Atwell, Simon Pegg, Ving Rhames, Pom Klementieff, Esai Morales, Shea Whigham, Greg Tarzan Davis, Henry Czerny and Angela Bassett. Keeping continuity, my guests this week are returnees from the 2023 podcast, my blockbuster crew David Johnson, DMD and Burton Brown. Does anyone remember what happened in Mission Impossible Dead Reckoning Part 1? Here's a callback to my synopsis from that podcast:Ethan Hunt and his team of Mission Impossiblers have to go rogue yet again to stop the world from  yada yada yada. Same old crap megalomaniac with a weapon this time it's AI. Or something.  Esai Morales is involved. I fell asleep twice so I didn't quite catch the relationship between the AI and Morales' Gabriel character.This movie seemed like more of the same old same old. But as a Tom Cruise running movie, it's a masterpiece, reaching an operatic Death in Venice level of running sophistication. So how does 2025's big follow up differ?This time Ethan Hunt and his rag tag team of crack superspies have to stop the AI Entity from blowing up the world as well as Gabriel from trying to harness its unbelievable power. Yet, instead of  running extravaganza, we are treated to the biggest boldest, hands down, accept no substitutes granddaddy of all info dump and flashback movies. Is it the best, the worst or somewhere in the middle of the series?Find out! Watch the video podcast on Youtube:https://youtu.be/dZfi-Cr8v20                                                                                                                                                       

The DMD is here! And Taryn tried to change a light at 345am!

The DMD is here! And we chat about what scared you as a kid!

Let's get it going! The DMD is here! And what was your crazy first day on the job?

This episode features Leila Zadeh, DMD, FAGD, who discusses advances in digital technology and the relatively recent incorporation of photogrammetry — a method of approximating a 3D structure using 2D images. She shares how it not only improves the accuracy of capturing implant relationships in a 3D space but also helps streamline the final impression process so that it is significantly faster and easier than traditional analog workflows. This story is the feature of an article in the May issue of AGD Impact. Dr. Zadeh is an advanced restorative dentist at digitalDDS and an adjunct assistant professor at NYU Langone Health's advanced education in general dentistry residency. She also creates educational content for Spear Education.

The DMD is here! And Danny went to see SIX the musical at Paramount! What did you get into because of your kids?

The DMD is here! We wanna know if you have witnessed any meltdowns!

The DMD is here! And we chat about pets!

The DMD is here! Plus we chat about cops and when they were mistakenly called to your house!

This week on Breaking Battlegrounds, Congressman Mike Simpson of Idaho joins the show for a wide-ranging conversation that begins with his shocking discovery of the scale of missing and murdered Indigenous women—over 6,000 annually—and how Congress is finally taking action on justice and jurisdictional reform. He also breaks down the future of nuclear power, America's path to energy independence, and the urgent need to end our reliance on hostile nations for critical minerals and pharmaceuticals. Then, Newsweek's Josh Hammer returns to discuss his new book Israel and Civilization, where he argues that Israel—and the Jewish people—are the West's first line of defense against rising global threats. He also tackles the disturbing surge of anti-Semitism on college campuses, exposes the failures of higher education, and calls for revoking tax-exempt status for elite universities like Harvard. Don't miss Kiley's Corner, where she dives into the chilling mystery of 11 dead women found in New England over the last 60 days—is it the work of a serial killer or 11 separate psychopaths? Tune in now!www.breakingbattlegrounds.voteTwitter: www.twitter.com/Breaking_BattleFacebook: www.facebook.com/breakingbattlegroundsInstagram: www.instagram.com/breakingbattlegroundsLinkedIn: www.linkedin.com/company/breakingbattlegroundsTruth Social: https://truthsocial.com/@breakingbattlegroundsShow sponsors:Invest Yrefy - investyrefy.com4Freedom MobileExperience true freedom with 4Freedom Mobile, the exclusive provider offering nationwide coverage on all three major US networks (Verizon, AT&T, and T-Mobile) with just one SIM card. Our service not only connects you but also shields you from data collection by network operators, social media platforms, government agencies, and more.Use code ‘Battleground' to get your first month for $9 and save $10 a month every month after.Learn more at: 4FreedomMobile.comDot VoteWith a .VOTE website, you ensure your political campaign stands out among the competition while simplifying how you reach voters.Learn more at: dotvote.voteAbout our guest:An Idaho native, Mike Simpson was born in Burley and raised in Blackfoot. Mike graduated from Utah State University and earned his DMD from Washington University School of Dental Medicine in St. Louis, Missouri. After graduation, Mike joined his father and uncle at the Simpson Family Dental Practice in Blackfoot before serving in the Blackfoot City Council and State Legislature.Mike's political career began in 1980, when he was elected to the Blackfoot City Council. In 1984, he was elected to the Idaho Legislature where he served until 1998, the last six years serving as Speaker. Mike is currently serving his fourteenth term in the House of Representatives for Idaho's Second Congressional District.Mike serves as Chairman of the House Interior and Environment Subcommittee on Appropriations. His position gives him the unique opportunity to fight for Idaho's priorities and ensure Idahoans' hard-earned tax dollars come back to Idaho instead of going to states like New York or California.Mike also serves on the House Energy and Water Development Subcommittee and the Labor, Health and Human Services, Education Subcommittee on Appropriations. The committees Mike serves on have jurisdiction over funding for several agencies and programs critical to Idaho, including the Department of Energy, the Department of the Interior, the Forest Service, the National Parks Service, the National Endowment for the Arts, the Smithsonian Institute, and the Department of Labor.Mike and his wife Kathy have been married for 50 years and have called Idaho home all their lives. The two enjoy spending time with their poodle, Charley, and enjoying Idaho's beautiful scenery.-Josh Hammer is a friend of the show and the senior editor-at-large at Newsweek. He's the host of The Josh Hammer Show and the author of a new book, Israel and Civilization: The Fate of the Jewish Nation and the Destiny of the West, which recently reached as high as No. 3 on all of Amazon. You can follow him on X @josh_hammer. Get full access to Breaking Battlegrounds at breakingbattlegrounds.substack.com/subscribe

Drug development activities focused on the rare, neuromuscular condition Duchenne muscular dystrophy have translated into functional improvements and an extension of life expectancy. Regenxbio is among several companies pursuing a gene therapy to treat Duchenne. Regenxbio believes both its microdystrophin—a truncated form of the dystrophin gene­ small enough to fit in a vector­—and the vector it is using, give it a competitive advantage over other efforts. We spoke Curran Simpson, CEO of Regenxbio, about the company's platform technology, the advantages he sees with its experimental DMD gene therapy, and how a partnership announced at the start of 2025 focused on a pair of other gene therapies provided a welcome alternative to tapping the capital markets.

Happy Tuesday! We have the DMD for you! And we talk NU METAL!

The DMD is here, and we are ready for a nice weather Friday! Plus the NFL Draft is here. Who did the Seahawks go with?

The DMD is here on a Thirsty Thursday! Plus we talk about a mom that called her baby ugly. So we call Migs' mom to ask if he was ugly! Will she answer?

The DMD is here! And we chat about Earth Day! And we have a simple question for you.

The DMD is here on a Tuesday! Let's chat about being young!

We are here. On a Monday! Might be a little chocolate drunk. Let's get to the DMD! And we chat about Easter and PHISH!

Hello! It's Thirsty Thursday and we wanna talk AI! Plus the DMD is here!

The DMD is here! And we talk about why Melinda Gates left Bill after 27 years!

My guest is Dr. Staci Whitman, DMD, a board-certified functional dentist for kids and adults. We discuss the critical importance of oral care and the oral microbiome for brain and bodily health. We examine the negative effects of common oral care product ingredients such as alcohol, astringents, and bleaches. We also explore the history and real impact of fluoridated drinking water on oral, bone, and systemic health. Then we discuss healthy, lesser-known solutions for bad breath, canker sores, cavities, and teeth whitening. We cover how teeth can be made to repair their own cavities and the connection between oral health and cardiovascular health, male and female fertility, dementia, and cancer. This episode goes far beyond the best approaches to brushing and flossing and will be a valuable resource for anyone seeking to improve their oral health and appearance at any age. Read the episode show notes at hubermanlab.com. Thank you to our sponsors AG1: https://drinkag1.com/huberman Eight Sleep: https://eightsleep.com/huberman BetterHelp: https://betterhelp.com/huberman Joovv: https://joovv.com/huberman Function: https://functionhealth.com/huberman LMNT: https://drinklmnt.com/huberman Timestamps 00:00:00 Dr. Staci Whitman 00:02:04 Oral Health & Oral Microbiome 00:05:01 Oral Healthcare Ingredients, Sodium Lauryl Sulfate (SLS); Canker Sores 00:08:45 Sponsors: Eight Sleep & BetterHelp 00:11:38 Cavities & Teeth De-/Remineralization, Fluoride 00:19:14 Cavities, Tool: Meal Frequency, Fasting 00:21:51 Sugar, “Dissolvable” Carbs & Cavities, Tools: Feed the Rainbow, Clean Diet 00:27:41 White Teeth, Bleaching, Hydroxyapatite, Mouth Breathing 00:34:34 Antibiotics, Gut & Oral Microbiome, Tool: Probiotics 00:36:20 Mouthwash, Alcohol, Astringents, Cardiovascular Risk, Bad Breath 00:39:54 Sponsors: AG1 & Joovv 00:42:21 Saliva, Dry Mouth, Salivary Analysis, Tools: Hydration; Nasal Breathing 00:47:23 Mouth vs. Nasal Breathing, Hard & Soft Tissue Issues 00:54:19 Deviated Septum, Therapies, Kids & Adults, Mouth Breathing & Sleep Disorders 01:00:42 Gum Health, Flossing; Sexual Health 01:01:50 Shifting to Nasal Breathing, Mouth Taping, Tools: 3-Minute Test, Kiss The Sky 01:05:53 Chewing Gum, Mastic Gum, Tool: Xylitol; Chewing Food, Breastfeeding 01:11:28 Sponsor: Function 01:13:15 Gum Disease, “Leaky Gums”, Cardiovascular Disease, Dementia, Cancer 01:20:05 Antibiotics, Ozone Therapy, Oil Pulling, Mold, Tool: Coconut Oil; Facial Trauma 01:28:07 Nicotine Gum & Pouches, Oral Health; Coffee, Teeth Whitening 01:34:16 Whole Foods, Hydroxyapatite Toothpaste; Tool: Testing Oral Microbiome 01:39:39 Water Fluoridation, History, Other Fluoride Sources, Neurocognitive Issues 01:54:57 Drinking Water & Fluoride, Toothpaste, Cavities 01:59:51 Sponsor: LMNT 02:01:07 Water Fluoridation & Levels 02:04:52 Oral Health & Fertility 02:07:03 Toothbrushing, Flossing, Waterpik, Tool: Toothbrushing & Meals 02:13:23 Teeth Spots & Markings, Fluorosis, Hypoplastic Enamel 02:19:10 Oral Health, Women, Pregnancy, Menopause & Burning Mouth 02:23:16 Geographic Tongue; Lip Balm; Mouth Breathing, Symmetrical Chewing 02:27:09 Tongue Tie, Chewing & Speech Function, Intervention 02:32:27 Red Light Therapy, Peptides & Exosomes 02:34:40 Mercury Fillings, Ceramic Composites, Retainers, Sealants 02:39:08 Dentists, Depression, Anxiety, Suicide; Insurance 02:45:05 Recap, Top Behavioral Tools for Oral Health, Tongue Scrapping 02:52:10 Zero-Cost Support, YouTube, Spotify & Apple Follow & Reviews, YouTube Feedback, Protocols Book, Social Media, Neural Network Newsletter Disclaimer & Disclosures